bangoland / Shutterstock.com
4 September 2025NewsAmericasMarisa Woutersen

Roche resolves cancer test dispute with Stanford affiliated startup

The deal brings to a close a clash over DNA sequencing technology for cancer detection, with both sides agreeing to dismiss their claims.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
19 August 2025   In a New Jersey lawsuit, Henlius and Organon are accused of submitting an aBLA for a biosimilar that infringes two dozen patents.
Americas
18 March 2025   Complaint centres on AI-powered tools for cancer diagnostics | Tempus says its rival has a history of deliberately copying competitors’ technologies.
Biotechnology
7 July 2020   A Roche subsidiary will be unable to block Amgen from producing the cancer drug Mvasi (bevacizumab), the Court of Appeals for the Federal Circuit has ruled.